Sanofi Pasteur's smallpox vaccine ACAM2000 business has been purchased by Emergent BioSolutions for up to $125 million. Under the terms of the deal, Sanofi will get $97.5 million upfront and up to $27.5 million for regulatory and manufacturing-related milestones.
Sanofi Pasteur's smallpox vaccine acquired by Emergent for $125M
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.